Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.blre.2020.100777 http://scihub22266oqcxt.onion/10.1016/j.blre.2020.100777 33199084!7648889!33199084     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Blood+Rev 2021 ; 47 (ä): 100777 Nephropedia Template TP {{tp|p=33199084|t=2021. A review on how to do hematology consults during COVID-19 pandemic |pdf=|usr=}}{{33199084}} gab.com Text A review on how to do hematology consults during COVID-19 pandemic JO: Blood Rev http://www.kidney.de/pget.php?&tw=1&pmid=33199084 #FOAvip The ongoing COVID-19 pandemic is the most trending and talked topic across the World. From its point of origin in Wuhan, China to clinical laboratory at NIH, a mere six-month-old SARS-CoV-2 virus is keeping the clinicians, and scientists busy at various fronts. However, COVID-19 is an emerging and evolving disease and each day brings in more data, new figures, and findings from the field of clinical practice. The role of hematologists has been increasingly recognized during the current pandemic because of several reasons. Most important of them are the characteristic hematological findings of COVID-19 patients that also have prognostic implications and that were not seen in other viral infections. The treatment of hematological complications in COVID-19 patients is very challenging given the critical care setting. There are interim and limited guidelines thus far due to the novelty of the disease. As this remains to be a quite fluid situation, all the appropriate medical societies including the major hematology bodies are proposing initial and interim guidelines (e.g. ASH guideline). This puts a hematologist on consult service in a dubious position where, he/she must tailor the recommendations on case to case basis. The purpose of this review is to provide the background context about the impact of COVID-19 on the blood system and to summarize the current interim guidelines to manage the associated hematological issues in COVID-19 infection. Twit Text FOAVip A review on how to do hematology consults during COVID-19 pandemic ????Blood Rev http://www.kidney.de/pget.php?&tw=1&pmid=33199084 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33199084 #FOAvip English Wikipedia <ref>{{Cite pmid|33199084}}</ref> A review on how to do hematology consults during COVID-19 pandemic #MMPMID33199084 Sahu KK; Cerny J Blood Rev 2021[May]; 47 (ä): 100777 PMID33199084show ga The ongoing COVID-19 pandemic is the most trending and talked topic across the World. From its point of origin in Wuhan, China to clinical laboratory at NIH, a mere six-month-old SARS-CoV-2 virus is keeping the clinicians, and scientists busy at various fronts. However, COVID-19 is an emerging and evolving disease and each day brings in more data, new figures, and findings from the field of clinical practice. The role of hematologists has been increasingly recognized during the current pandemic because of several reasons. Most important of them are the characteristic hematological findings of COVID-19 patients that also have prognostic implications and that were not seen in other viral infections. The treatment of hematological complications in COVID-19 patients is very challenging given the critical care setting. There are interim and limited guidelines thus far due to the novelty of the disease. As this remains to be a quite fluid situation, all the appropriate medical societies including the major hematology bodies are proposing initial and interim guidelines (e.g. ASH guideline). This puts a hematologist on consult service in a dubious position where, he/she must tailor the recommendations on case to case basis. The purpose of this review is to provide the background context about the impact of COVID-19 on the blood system and to summarize the current interim guidelines to manage the associated hematological issues in COVID-19 infection. |COVID-19/blood/*complications/epidemiology/therapy[MESH] |Disease Management[MESH] |Hematologic Diseases/blood/*etiology/therapy[MESH] |Hematology[MESH] |Humans[MESH] |Pandemics[MESH] |Practice Guidelines as Topic[MESH]A review on how to do hematology consults during COVID-19 pandemic (epmc).pdf DeepDyve Pubget Overpricing